第一作者:
David M,Weinreich
第一单位:
From Regeneron Pharmaceuticals, Tarrytown (D.M.W., T.N., S.A., H.G., R.B., J.X., A.T.H., J.D.H., B.J.M., D.R., M.H., J.I., D.Y.A., C. Perry, C. Pan, A.M., R.H., J.D.D., K.C.T., A.B., C.A.K., Y.K., A.C., W.K., B.K., A.T.D., Y. S., G.P.G., N.S., L.L., N.B., G.H., G.D.Y.) and Excision BioTherapeutics, New York (S.S.) - both in New York; Bio-Medical Research (L.R.-G.) and Universal Medical and Research Center (G.A.) - both in Miami; Hope Clinical Research, Canoga Park, CA (H.A.); PMG Research of Wilmington, Wilmington, NC (K.C.); Köhler and Milstein Research, Hospital General Agustín O'Horan, Mérida, Mexico (J.A.S.-C.); and the Willis-Knighton Physician Network, Shreveport, LA (J.A.B).
作者:
主题词
青少年(Adolescent);成年人(Adult);抗体, 中和(Antibodies, Neutralizing);抗病毒药(Antiviral Agents);剂量效应关系, 药物(Dose-Response Relationship, Drug);双盲法(Double-Blind Method);复方合剂(Drug Combinations);女(雌)性(Female);住院(Hospitalization);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);中年人(Middle Aged);妊娠(Pregnancy);妊娠并发症, 感染性(Pregnancy Complications, Infectious);比例危险度模型(Proportional Hazards Models);病毒载量(Viral Load);青年人(Young Adult)
DOI
10.1056/NEJMoa2108163
PMID
34587383
发布时间
2025-01-31
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文